groups II and III were in pre-obese category (BMI: 26.3 ± 4.2 and 25.5 ± 3.7)
respectively. The statistical significant difference observed among the three groups were in waist circumference (p<0.0001), hip circumference (p = 0.002) and waist hip ratio (p = 0.03). This was probably due to high visceral and subcutaneous fat deposition as evidenced by high skin fold thickness in triceps region (p = 0.003).
 Serum calcium was normal in groups I and II (9.5 ± 0.5 mg/dl and 9.0 ± 0.4 mg/dl respectively), while it was in the lower limits of normal (8.4 ± 0.4 mg/dl) in group III. 25 OH vitamin D level was insufficient in groups I and II (25.3 ± 8.3 ng/ml and 21.4 ± 8.1 ng/ml respectively) while it was deficient in group III (19.3 ± 7.2 ng/ml) and with statistical significant difference of p = 0.001.
 hs-CRP levels were increased in groups II and III when compared with group I (p<0.04). The pathogenic damages occurred in the bone was mediated by interaction of inflammatory cells, cytokines, etc.
 High serum total cholesterol and LDLc levels were observed in groups II & III compared to group I.
 Group III had decreased serum sclerostin level of 4.62 ± 1.6 ng/ml compared with group I (5.74±1.3 ng/ml) and group II (4.92±1.4 ng/ml), with statistical significant difference of p<0.0001. It could be due to decreased sclerostin expression caused by apoptosis of osteocytes or deficiency of estrogen or testosterone.
 Serum PINP level was decreased in groups III (178.7 ± 123 pg/ml) and group II (161.2 ± 150 pg/ml) compared with group I (251.5 ± 228 pg/ml). Serum PINP considered as a bone formation marker, was decreased in group III due to less bone formation compared to bone resorption with a significance of p = 0.014.
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Page 159  Serum NTX-I was 219.09 ± 71 ng/ml in group I, 292.1 ± 110 ng/ml in group II and 333.9 ± 322 ng/ml in group III; (p = 0.008). The elevated levels were seen in group III due to increased bone resorption.
 Serum CTX-I in group I was 0.81 ± 0.47 ng/ml, in group II 1.07 ± 0.7 ng/ml and in group III 1.14 ± 0.6 ng/ml; (p = 0.02). Serum CTX-I is identified as bone resorption marker.
 Group III had mean adiponectin level of 4.6 ± 2.6 µg/mL, group II had 5.2 ± 2.9 µg/mL and group I had 3.96 ± 2.3 µg/mL; (p = 0.044). The increased levels of adiponectin in groups II & III indicated increased adiposity of bone marrow and visceral fat.  The cut-off level of serum sclerostin (5.6 ng/mL, sensitivity-75%, specifity-70%), serum PINP (171 pg/mL, sensitivity-75%, specifity-70%) and serum CTX-I (0.83
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Page 160 ng/mL, sensitivity-66%, specifity-60%) was derived for the diagnosis of osteoporosis. 
